{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:33:45Z","timestamp":1780684425201,"version":"3.54.1"},"reference-count":35,"publisher":"Consortium of Multiple Sclerosis Centers","issue":"Q3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,1]]},"abstract":"<jats:title>CE INFORMATION<\/jats:title>\n               <jats:p>ACTIVITY AVAILABLE ONLINE: To access the article and evaluation online, go to https:\/\/www.highmarksce.com\/mscare.<\/jats:p>\n               <jats:p>TARGET AUDIENCE: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, social workers, and other health care providers involved in the management of patients with multiple sclerosis (MS).<\/jats:p>\n               <jats:p>LEARNING OBJECTIVES:<\/jats:p>\n               <jats:p>Recognize that Black people with MS may have barriers to care that potentially contribute to a more aggressive disease course in order to better address potential barriers to care. Construct patient-centered, team-focused diagnostic and management plans for Black people with suspected or diagnosed MS in order to provide clinical support that may improve outcomes.<\/jats:p>\n               <jats:p>ACCREDITATION:<\/jats:p>\n               <jats:p>In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Intellisphere, LLC. The CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.<\/jats:p>\n               <jats:p\/>\n               <jats:p>This activity was planned by and for the health care team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credit for learning and change.<\/jats:p>\n               <jats:p>PHYSICIANS: The CMSC designates this journal-based activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)\u2122. Physicians should claim only the credit commensurate with the extent of their participation in the activity.<\/jats:p>\n               <jats:p>NURSES: The CMSC designates this enduring material for 0.75 contact hour of nursing continuing professional development (NCPD) (none in the area of pharmacology).<\/jats:p>\n               <jats:p>PSYCHOLOGISTS: This activity is awarded 0.75 CE credits.<\/jats:p>\n               <jats:p>SOCIAL WORKERS: As a Jointly Accredited Organization, the CMSC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 0.75 general continuing education credits.<\/jats:p>\n               <jats:p>DISCLOSURES: It is the policy of the CMSC to mitigate all relevant financial disclosures from planners, faculty, and other persons that can affect the content of this CE activity. For this activity, all relevant disclosures have been mitigated.<\/jats:p>\n               <jats:p>Francois Bethoux, MD, editor in chief of the International Journal of MS Care (IJMSC), and Alissa Mary Willis, MD, associate editor of IJMSC, have disclosed no relevant financial relationships. Authors Elissa M. Dykes, MD; Ghaida K. Zaid, MD; Surachat Ngorsuraches, PhD; and William Meador, MD, have disclosed no relevant financial relationships.<\/jats:p>\n               <jats:p>The staff at IJMSC, CMSC, and Intellisphere, LLC, who are in a position to influence content, have disclosed no relevant financial relationships. Laurie Scudder, DNP, NP, CMSC continuing education director, has served as a planner and reviewer for this activity. She has disclosed no relevant financial relationships.<\/jats:p>\n               <jats:p>METHOD OF PARTICIPATION:<\/jats:p>\n               <jats:p>Release Date: July 1, 2024; Valid for Credit through: July 1, 2025<\/jats:p>\n               <jats:p>To receive CE credit, participants must:<\/jats:p>\n               <jats:p>(1) Review the continuing education information, including learning objectives and author disclosures. (2) Study the educational content. (3) Complete the evaluation, which is available at https:\/\/www.highmarksce.com\/mscare.<\/jats:p>\n               <jats:p>Statements of Credit are awarded upon successful completion of the evaluation. There is no fee to participate in this activity.<\/jats:p>\n               <jats:p>DISCLOSURE OF UNLABELED USE: This educational activity may contain discussion of published and\/or investigational uses of agents that are not approved by the FDA. The CMSC and Intellisphere, LLC, do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the CMSC or Intellisphere, LLC.<\/jats:p>\n               <jats:p>DISCLAIMER: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health care professionals without first evaluating their patients\u2019 conditions, considering possible contraindications or risks, reviewing any applicable manufacturer\u2019s product information, and comparing any therapeutic approach with the recommendations of other authorities.<\/jats:p>","DOI":"10.7224\/1537-2073.2023-084","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:18:20Z","timestamp":1719926300000},"page":"167-173","source":"Crossref","is-referenced-by-count":2,"title":["Descriptive Analysis of Health Disparities Between Black and White People With Multiple Sclerosis in the Deep South"],"prefix":"10.7224","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4576-6646","authenticated-orcid":false,"given":"Elissa M.","family":"Dykes","sequence":"first","affiliation":[{"name":"From the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaida K.","family":"Zaid","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surachat","family":"Ngorsuraches","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, Auburn, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Meador","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4242","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"issue":"2","key":"2024071814481389500_i1537-2073-26-167-b1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"2024071814481389500_i1537-2073-26-167-b2","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"2024071814481389500_i1537-2073-26-167-b3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","article-title":"Population-based estimates for the prevalence of multiple sclerosis in the United States by race, ethnicity, age, sex, and geographic region","volume":"80","author":"Hittle","year":"2023","journal-title":"JAMA Neurol"},{"issue":"19","key":"2024071814481389500_i1537-2073-26-167-b4","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1212\/WNL.0b013e3182918cc2","article-title":"Incidence of multiple sclerosis in multiple racial and ethnic groups","volume":"80","author":"Langer-Gould","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"2024071814481389500_i1537-2073-26-167-b5","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1212\/01.WNL.0000145762.60562.5D","article-title":"Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis","volume":"63","author":"Cree","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"2024071814481389500_i1537-2073-26-167-b6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1212\/01.wnl.0000208505.81912.82","article-title":"Does multiple sclerosis-associated disability differ between races?","volume":"66","author":"Marrie","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"2024071814481389500_i1537-2073-26-167-b7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/1352458506070923","article-title":"Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review","volume":"12","author":"Naismith","year":"2006","journal-title":"Mult Scler"},{"issue":"1-2","key":"2024071814481389500_i1537-2073-26-167-b8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000484213","article-title":"Multiple sclerosis mortality by race\/ethnicity, age, sex, and time period in the United States, 1999-2015","volume":"50","author":"Amezcua","year":"2018","journal-title":"Neuroepidemiology"},{"issue":"11","key":"2024071814481389500_i1537-2073-26-167-b9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1177\/1352458519863764","article-title":"The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States","volume":"26","author":"Beecham","year":"2020","journal-title":"Mult Scler"},{"issue":"8","key":"2024071814481389500_i1537-2073-26-167-b10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254945","article-title":"Genetic susceptibility to multiple sclerosis in African Americans","volume":"16","author":"Goodin","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"2024071814481389500_i1537-2073-26-167-b11","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jamaneurol.2021.3416","article-title":"Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review","volume":"78","author":"Amezcua","year":"2021","journal-title":"JAMA Neurol"},{"issue":"1","key":"2024071814481389500_i1537-2073-26-167-b12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12883-020-01749-6","article-title":"Multiple sclerosis in a multi-ethnic population from Northern California: a retrospective analysis, 2010-2016","volume":"20","author":"Romanelli","year":"2020","journal-title":"BMC Neurol"},{"key":"2024071814481389500_i1537-2073-26-167-b13","doi-asserted-by":"crossref","first-page":"104413","DOI":"10.1016\/j.msard.2022.104413","article-title":"Disability outcomes in early-stage African American and White people with multiple sclerosis","volume":"69","author":"Petracca","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"14","key":"2024071814481389500_i1537-2073-26-167-b14","doi-asserted-by":"crossref","first-page":"e1548","DOI":"10.1212\/WNL.0000000000009210","article-title":"Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis","volume":"94","author":"Amezcua","year":"2020","journal-title":"Neurology"},{"issue":"9","key":"2024071814481389500_i1537-2073-26-167-b15","doi-asserted-by":"crossref","first-page":"e881","DOI":"10.1212\/WNL.0000000000012362","article-title":"Association of disease severity and socioeconomic status in Black and White Americans with multiple sclerosis","volume":"97","author":"Gray-Roncal","year":"2021","journal-title":"Neurology"},{"issue":"11","key":"2024071814481389500_i1537-2073-26-167-b16","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/brain\/awy245","article-title":"Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study","volume":"141","author":"Caldito","year":"2018","journal-title":"Brain"},{"key":"2024071814481389500_i1537-2073-26-167-b17","doi-asserted-by":"crossref","first-page":"105089","DOI":"10.1016\/j.msard.2023.105089","article-title":"Perceptions of people with multiple sclerosis on social determinants of health: mixed methods","volume":"80","author":"Mateen","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"2024071814481389500_i1537-2073-26-167-b18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1191\/1352458505ms1215oa","article-title":"Multiple sclerosis management for low-income minorities","volume":"11","author":"Shabas","year":"2005","journal-title":"Mult Scler"},{"issue":"8","key":"2024071814481389500_i1537-2073-26-167-b19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/1352458508092263","article-title":"Comorbidity, socioeconomic status and multiple sclerosis","volume":"14","author":"Marrie","year":"2008","journal-title":"Mult Scler"},{"issue":"12","key":"2024071814481389500_i1537-2073-26-167-b20","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1093\/brain\/awab342","article-title":"Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis","volume":"144","author":"Vasileiou","year":"2021","journal-title":"Brain"},{"key":"2024071814481389500_i1537-2073-26-167-b21","doi-asserted-by":"crossref","first-page":"103451","DOI":"10.1016\/j.msard.2021.103451","article-title":"The impact of socioeconomic status on mental health and health-seeking behavior across race and ethnicity in a large multiple sclerosis cohort","volume":"58","author":"Pimentel Maldonado","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"2024071814481389500_i1537-2073-26-167-b22","doi-asserted-by":"crossref","first-page":"103734","DOI":"10.1016\/j.msard.2022.103734","article-title":"Association of socioeconomic disadvantage and neighborhood disparities with clinical outcomes in multiple sclerosis patients","volume":"61","author":"Abbatemarco","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"2024071814481389500_i1537-2073-26-167-b23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1177\/13524585231185046","article-title":"Social determinants of health and disparate disability accumulation in a cohort of Black, Hispanic, and White patients with multiple sclerosis","volume":"29","author":"Orlando","year":"2023","journal-title":"Mult Scler"},{"issue":"18","key":"2024071814481389500_i1537-2073-26-167-b24","doi-asserted-by":"crossref","first-page":"e1810","DOI":"10.1212\/WNL.0000000000200150","article-title":"The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs","volume":"98","author":"Bebo","year":"2022","journal-title":"Neurology"},{"issue":"13","key":"2024071814481389500_i1537-2073-26-167-b25","doi-asserted-by":"crossref","first-page":"e1497","DOI":"10.1212\/WNL.0000000000007190","article-title":"Socioeconomic status and disability progression in multiple sclerosis: a multinational study","volume":"92","author":"Harding","year":"2019","journal-title":"Neurology"},{"key":"2024071814481389500_i1537-2073-26-167-b26","doi-asserted-by":"crossref","first-page":"101930","DOI":"10.1016\/j.msard.2020.101930","article-title":"Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients","volume":"40","author":"Calocer","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"962","key":"2024071814481389500_i1537-2073-26-167-b27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/pgmj.2004.028274","article-title":"Diabetes in African Americans","volume":"81","author":"Marshall","year":"2005","journal-title":"Postgrad Med J"},{"issue":"360","key":"2024071814481389500_i1537-2073-26-167-b28","first-page":"1","article-title":"Prevalence of obesity and severe obesity among adults: United States, 2017-2018","author":"Hales","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"8","key":"2024071814481389500_i1537-2073-26-167-b29","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1474-4422(10)70135-6","article-title":"Emerging effects of comorbidities on multiple sclerosis","volume":"9","author":"Marrie","year":"2010","journal-title":"Lancet Neurol"},{"issue":"13","key":"2024071814481389500_i1537-2073-26-167-b30","doi-asserted-by":"crossref","first-page":"e1322","DOI":"10.1212\/WNL.0000000000012610","article-title":"Interface of multiple sclerosis, depression, vascular disease, and mortality: a population-based matched cohort study","volume":"97","author":"Palladino","year":"2021","journal-title":"Neurology"},{"issue":"8","key":"2024071814481389500_i1537-2073-26-167-b31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/1352458519845836","article-title":"Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis","volume":"26","author":"Fitzgerald","year":"2020","journal-title":"Mult Scler"},{"issue":"12","key":"2024071814481389500_i1537-2073-26-167-b32","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1177\/1352458520984746","article-title":"Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohort","volume":"27","author":"Fitzgerald","year":"2021","journal-title":"Mult Scler"},{"issue":"2","key":"2024071814481389500_i1537-2073-26-167-b33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.apmr.2021.10.011","article-title":"Differences in cardiometabolic comorbidities between Black and White persons living with multiple sclerosis","volume":"103","author":"Chase","year":"2022","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"2024071814481389500_i1537-2073-26-167-b34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/jnnp-2022-329685","article-title":"Association of obesity with disease outcome in multiple sclerosis","volume":"94","author":"Lutfullin","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10077","key":"2024071814481389500_i1537-2073-26-167-b35","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: evidence and interventions","volume":"389","author":"Bailey","year":"2017","journal-title":"Lancet"}],"container-title":["International Journal of MS Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/26\/Q3\/167\/3402246\/i1537-2073-26-167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/26\/Q3\/167\/3402246\/i1537-2073-26-167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T21:12:14Z","timestamp":1752786734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijmsc.org\/view\/descriptive-analysis-of-health-disparities-between-black-and-white-people-with-multiple-sclerosis-in-the-deep-south"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":35,"journal-issue":{"issue":"Q3","published-online":{"date-parts":[[2024,7,1]]},"published-print":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.7224\/1537-2073.2023-084","relation":{},"ISSN":["1537-2073"],"issn-type":[{"value":"1537-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,1]]}}}